Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 1
1967 2
1968 2
1969 4
1970 3
1971 5
1972 12
1973 3
1974 14
1975 8
1976 19
1977 19
1978 21
1979 27
1980 36
1981 45
1982 61
1983 97
1984 102
1985 112
1986 132
1987 154
1988 136
1989 172
1990 186
1991 191
1992 174
1993 225
1994 219
1995 236
1996 277
1997 279
1998 285
1999 273
2000 320
2001 374
2002 397
2003 449
2004 435
2005 452
2006 437
2007 492
2008 531
2009 536
2010 566
2011 594
2012 644
2013 661
2014 704
2015 785
2016 765
2017 769
2018 780
2019 880
2020 1038
2021 1070
2022 981
2023 940
2024 882
2025 913
2026 743

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19,202 results

Results by year

Filters applied: . Clear all
Page 1
Graft-versus-host disease.
Moreno DF, Cid J. Moreno DF, et al. Med Clin (Barc). 2019 Jan 4;152(1):22-28. doi: 10.1016/j.medcli.2018.07.012. Epub 2018 Oct 9. Med Clin (Barc). 2019. PMID: 30309668 Review. English, Spanish.
Graft-versus-host disease (GVHD) is the most frequent and potentially fatal complication of an allogeneic hematopoietic progenitor cell transplantation. ...The clinical picture of this immune response is called acute and chronic GVHD. Acute …
Graft-versus-host disease (GVHD) is the most frequent and potentially fatal complication of an allogeneic hemato …
Review of Graft-Versus-Host Disease.
Ramachandran V, Kolli SS, Strowd LC. Ramachandran V, et al. Dermatol Clin. 2019 Oct;37(4):569-582. doi: 10.1016/j.det.2019.05.014. Epub 2019 Jul 10. Dermatol Clin. 2019. PMID: 31466596 Review.
Graft-versus-host disease (GVHD) is an adverse immunologic phenomenon following allogenic hematopoietic stem cell transplant. Cutaneous manifestations are the earliest and most common presentation of the disease. This article describes the patho …
Graft-versus-host disease (GVHD) is an adverse immunologic phenomenon following allogenic hematopoietic stem cel …
Ocular graft-versus-host disease (oGVHD): From A to Z.
Soleimani M, Mahdavi Sharif P, Cheraqpour K, Koganti R, Masoumi A, Baharnoori SM, Salabati M, Djalilian AR. Soleimani M, et al. Surv Ophthalmol. 2023 Jul-Aug;68(4):697-712. doi: 10.1016/j.survophthal.2023.02.006. Epub 2023 Mar 2. Surv Ophthalmol. 2023. PMID: 36870423 Free PMC article. Review.
Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of disorders. One of the complications is acute graft-versus-host disease (aGVHD), which has a high mortality rate. Patients can also develop chronic gra …
Allogeneic hematopoietic stem cell transplantation is a definitive therapy for a variety of disorders. One of the complications is acute …
Acute Graft-Versus-Host Disease: A Brief Review.
Aladağ E, Kelkitli E, Göker H. Aladağ E, et al. Turk J Haematol. 2020 Feb 20;37(1):1-4. doi: 10.4274/tjh.galenos.2019.2019.0157. Epub 2019 Sep 2. Turk J Haematol. 2020. PMID: 31475512 Free PMC article. Review.
Graft-versus-host disease (GvHD) is an important complication that can be observed after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Acute GvHD (aGvHD) is seen after allo-HSCT and the incidence of aGvHD is around 30%-50%. aGv …
Graft-versus-host disease (GvHD) is an important complication that can be observed after allogeneic hematopoieti …
Resolution of acute intestinal graft-versus-host disease.
Thiagarajan S, Neurath MF, Hildner K. Thiagarajan S, et al. Semin Immunopathol. 2019 Nov;41(6):655-664. doi: 10.1007/s00281-019-00769-w. Epub 2019 Oct 31. Semin Immunopathol. 2019. PMID: 31673757 Review.
Despite its lifesaving potential, immune-mediated allo-reactivity inherent to the allogeneic transplantation can be observed within up to 50% of all allo-HCT patients regularly resulting in the manifestation of acute and/or chronic graft-versus-host …
Despite its lifesaving potential, immune-mediated allo-reactivity inherent to the allogeneic transplantation can be observed within up to 50 …
Acute Graft-versus-Host Disease: Emerging Insights and Updates into Detection, Prevention, and Treatment.
DiMaggio E. DiMaggio E. Pharmacotherapy. 2020 Aug;40(8):788-807. doi: 10.1002/phar.2436. Epub 2020 Jul 27. Pharmacotherapy. 2020. PMID: 32530080 Review.
Acute graft-versus-host disease remains a devastating complication following hematopoietic cell transplantation, resulting in increased morbidity and mortality. Vast research efforts continue to refine or develop new means of prediction, assessm …
Acute graft-versus-host disease remains a devastating complication following hematopoietic cell transplan …
International, Multicenter Standardization of Acute Graft-versus-Host Disease Clinical Data Collection: A Report from the Mount Sinai Acute GVHD International Consortium.
Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, Chanswangphuwana C, Efebera YA, Holler E, Litzow M, Ordemann R, Qayed M, Renteria AS, Reshef R, Wölfl M, Chen YB, Goldstein S, Jagasia M, Locatelli F, Mielke S, Porter D, Schechter T, Shekhovtsova Z, Ferrara JL, Levine JE. Harris AC, et al. Biol Blood Marrow Transplant. 2016 Jan;22(1):4-10. doi: 10.1016/j.bbmt.2015.09.001. Epub 2015 Sep 16. Biol Blood Marrow Transplant. 2016. PMID: 26386318 Free PMC article.
Acute graft-versus-host disease (GVHD) remains a leading cause of morbidity and nonrelapse mortality after allogeneic hematopoietic cell transplantation. ...
Acute graft-versus-host disease (GVHD) remains a leading cause of morbidity and nonrelapse mortality afte …
Graft-versus-host disease.
Choi S, Reddy P. Choi S, et al. Panminerva Med. 2010 Jun;52(2):111-24. Panminerva Med. 2010. PMID: 20517195 Review.
The number of allogeneic hematopoietic cell transplantations (HCT) continues to increase with more than 20000 allogeneic transplantations performed annually. The graft-versus-leukemia / tumor (GVL) effect during allogeneic HCT effectively eradicates many hematologic …
The number of allogeneic hematopoietic cell transplantations (HCT) continues to increase with more than 20000 allogeneic transplantations pe …
Engraftment Syndrome and Acute Graft-versus-Host Disease: A Meta-Analysis.
Poonsombudlert K, Kewcharoen J, Prueksapraopong C, Limpruttidham N. Poonsombudlert K, et al. Hawaii J Health Soc Welf. 2020 Jun 1;79(6):194-201. Hawaii J Health Soc Welf. 2020. PMID: 32524098 Free PMC article.
Engraftment syndrome (ES) has been associated with the surge of neutrophils and cytokines, which is similar to the presumed underlying pathophysiology behind acute graft-versus-host disease (aGVHD). However, there has been no meta-analysis to ev …
Engraftment syndrome (ES) has been associated with the surge of neutrophils and cytokines, which is similar to the presumed underlying patho …
19,202 results
You have reached the last available page of results. Please see the User Guide for more information.